GlassScriptPhysician profile
John T Atkins
NPI 1487638169
$1,647.99
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,511 · 2020: $45.74 · 2022: $37.65 · 2023: $53.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $541.54 | 2019-2023 | |
| Glaxosmithkline, LLC. | $492.30 | 2019-2020 | |
| Philips North America LLC | $100.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $75.33 | 2019 | |
| Grifols USA, LLC | $66.93 | 2019 | |
| Insmed, INC. | $58.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.01 | 2019 | |
| Merck Sharp & Dohme LLC | $43.87 | 2019 | |
| Genentech USA, INC. | $41.13 | 2019 | |
| Sunovion Pharmaceuticals INC. | $35.94 | 2019-2020 | |
| Resmed Corp | $33.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.31 | 2019 | |
| Chiesi USA, INC. | $20.04 | 2022 | |
| Genzyme Corporation | $18.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.61 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $12.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Atkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.